DIH Holding US, Inc. (DHAI)
NASDAQ: DHAI · Real-Time Price · USD
0.492
-0.036 (-6.84%)
At close: Feb 21, 2025, 4:00 PM
0.480
-0.011 (-2.34%)
After-hours: Feb 21, 2025, 6:59 PM EST

Company Description

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific.

It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement.

The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research.

In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software.

DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.

DIH Holding US, Inc.
DIH Holding US logo
Country United States
Founded 2007
Industry Medical Devices
Sector Healthcare
CEO Jason Chen

Contact Details

Address:
77 Accord Park Drive, Suite D-1
Norwell, Massachusetts 02061
United States
Phone 617 871 2101
Website dih.com

Stock Details

Ticker Symbol DHAI
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001883788
CUSIP Number 23290B106
ISIN Number US23290B1061
SIC Code 3841

Key Executives

Name Position
Jason Chen Founder, Chairman and Chief Executive Officer
Lynden Bass Chief Financial Officer and Director
Patrick Bruno CMO of Hospital and Clinical Solutions Division and Director
Dietmar Dold Chief Operating Officer
Slavko Skafar Senior Vice President of? Sales ? EMEA Indirect?
Walther Geiger Vice President of Global Operations

Latest SEC Filings

Date Type Title
Feb 18, 2025 424B3 Prospectus
Feb 18, 2025 424B3 Prospectus
Feb 14, 2025 424B3 Prospectus
Feb 14, 2025 424B3 Prospectus
Feb 14, 2025 10-Q Quarterly Report
Feb 14, 2025 8-K Current Report
Feb 13, 2025 8-K Current Report
Feb 5, 2025 8-K Current Report
Feb 4, 2025 8-K Current Report
Feb 3, 2025 SCHEDULE 13G Filing